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Abstract
Background: Family history is important for identifying candidates for high risk cancer screening and referral for
genetic counseling. We sought to determine the percentage of individuals who would be eligible for high risk
cancer screening or genetic referral and testing if family history includes an extended (vs limited) family history.
Methods: Family histories were obtained from 626 women at UVMMC associated mammography centers from
2001 to 2002. ACS guidelines were used to determine eligibility for high risk breast or colon cancer screening.
Eligibility for referral for genetic counseling for hereditary breast and colon cancer was determined using the
Referral Screening Tool and Amsterdam II screening criteria, respectively. All family histories were assessed for
eligibility by a limited history (first degree relatives only) and extended history (first and second degree relatives).
Results: Four hundred ninety-nine histories were eligible for review. 18/282 (3.6 %) and 62/123 (12 %) individuals
met criteria for high risk breast and colon cancer screening, respectively. 13/18 (72 %) in the high risk breast cancer
screening group and 12/62 (19 %) in the high risk colon cancer screening group met criteria based upon an
extended family history. 9/282 (1.8 %) and 31/123 (6.2 %) individuals met criteria for genetic counseling referral and
testing for breast and colon cancer, respectively. 2/9 (22 %) of individuals in the genetic breast cancer screening
group and 21/31 (68 %) individuals in the genetic colon cancer screening group met criteria based upon extended
family history.
Conclusions: This is one of the first studies to suggest that first degree family history alone is not adequate for
identification of candidates for high risk screening and referral for genetic counseling for hereditary breast and
colon cancer syndromes. A larger population is needed to further validate this data.
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Background
A family history of colorectal or breast cancer may sig-
nificantly impact screening and management strategies
for patients. Individuals with a positive family history of
colon cancer may be candidates for earlier initiation of
colonoscopy. Individuals with a positive family history of
breast cancer may be candidates for screening breast
MRI or be eligible for prevention strategies (i.e., chemo-
prophylaxis and/or surgical prophylaxis including bilat-
eral mastectomy and bilateral salpingo-oophorectomy)
[1]. Furthermore, individuals with a family history sug-
gesting a hereditary cancer syndrome, such as Lynch
syndrome or hereditary breast and ovarian cancer syn-
drome, should be referred for genetic counseling and/or
genetic testing. Multiple guidelines for breast and colon
cancer high risk screening and referral for genetic counsel-
ing and genetic testing require knowledge of first, second
and occasionally third degree relatives [2–5].
Although obtaining a family history is a staple of pri-
mary care management, there are significant barriers to
obtaining a complete and accurate family history.
These barriers include time restraints, patient know-
ledge and lack of perceived importance by healthcare
provider [6, 7]. A key barrier is the lack of standardization
of required information. The gold standard family history
is a five generation pedigree used in medical genetics
and genetic counseling [8]. Recently, the American So-
ciety of Clinical Oncology (ASCO) has suggested that a
minimum family history for oncology patients should
include first and second degree relatives, type of cancer,
age at cancer diagnosis and lineage (maternal and/or
paternal) [9].
Providers commonly obtain information from first de-
gree relatives but less commonly obtain a more extended
family history or age at cancer diagnosis [10, 11]. The
current cross-sectional study was undertaken to deter-
mine the value of an extended (first and second degree)
family history compared to a limited (first degree only)
family history in determining eligibility for high risk
screening and referral for genetic counseling for breast
or colon cancer.
Methods
Women presenting for breast cancer screening at one
of several mammography facilities associated with the
University of Vermont Medical Center (UVMMC) were
given the opportunity to complete and return a family
history questionnaire. All women were invited to partici-
pate including those for asymptomatic screening and
symptomatic referrals. The average age was 63 years and
100 % were female. A consent form was attached to the
front of the questionnaire providing a description of the
study and requesting permission to use information for
this study. Permission was also obtained to contact
patients for clarification of information on the question-
naire if necessary. Questionnaires were distributed be-
tween May 2001 and May 2002. The study was approved
by the UVMMC IRB.
Questionnaire
Information on all related family members was obtained
via questionnaire (see Additional file 1) including gender,
lineage (maternal or paternal), relatedness (sibling, par-
ents, aunts, uncles, etc.), primary cancer and age at diag-
nosis. This questionnaire has been developed and pilot
tested in the Familial Cancer Program at the University
of Vermont Cancer Center.
Screening guidelines and risk models utilized
Breast Cancer Screening Guidelines and Models for Risk
Assessment: The American Cancer Society (ACS) and
National Comprehensive Cancer Network (NCCN) con-
sider women as high risk with a greater than 20 % life-
time risk of breast cancer due to family history and
recommend adding annual screening breast magnetic
resonance imaging (MRI) to their annual mammogram
for breast cancer screening [3, 12]. We calculated risk of
developing breast cancer based on family history using
the Claus Model [13]. This model uses first and second
degree family history and age at cancer diagnosis to de-
termine risk. While other models exist (Gail, Tyrer-
Cuzick, etc.), the Claus model is the only model which
calculates risk solely based on family history. Therefore,
the Claus model would not confound the results with
factors affecting risk beyond family history.
There are several guidelines regarding referral for genetic
counseling and testing for hereditary breast cancer includ-
ing guidelines from American College of Obstetrics and
Gynecology (ACoSOG), the National Comprehensive Can-
cer Network (NCCN) and the US Preventative Service
Task Force (USPSTF) [4, 14, 15]. We chose to use the
USPSTF guidelines as they include an extended family his-
tory and are easy to administer. The USPSTF recommends
consideration of several validated screening tools including
the Referral Screening Tool (RST). The RST is one of the
easiest to use and therefore appropriate for busy primary
care providers [16]. The RST includes first or second de-
gree relatives 50 years or younger with history of breast
cancer, any first or second degree relative with ovarian can-
cer, male breast cancer or greater than one family member
on the same side of the family over the age of 50 with
breast cancer. Patients should be referred for genetic
counseling if they meet two or more of these criteria.
Colorectal Cancer Screening Guidelines and Models
for Risk Assessment: Several guidelines exist for colon
cancer screening; however, only the ACS includes ex-
tended family history in recommendations for high
risk individuals. These recommendations suggest that
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screening begin at age 40 for individuals with any first
degree or two second degree relatives at any age with
a history of colorectal cancer [17].
Guidelines for referral for genetic counseling or testing
for hereditary colon cancer for individuals with no per-
sonal history of colorectal cancer have not been devel-
oped at this time. However, Hampel at al. suggest that
individuals with a lifetime relative risk (RR) ratio of
greater than 2.0 be referred for genetic counseling [18].
This criteria can be met using the Amsterdam II criteria
[19]. Individuals meet criteria if they have one or more
of the following: three or more first or second degree
relatives with any HNPCC associated cancers, one rela-
tive with two or more HNPCC associated cancers or
one first degree relative with colorectal cancer less than
50 years old.
Statistical analysis
All questionnaires were transcribed into a Microsoft Access
database. Each study participant was assigned a unique,
random identification number to allow depersonalization of
data. The data was queried for individuals with at least
one relative with a primary cancer excluding non-
melanomatous skin cancers. This data was then queried
to determine individuals who met specific guideline cri-
teria based on their first degree family history followed




Six hundred twenty-six family history questionnaires were
returned between May 2001 and May 2002. Question-
naires were excluded from this analysis if they were not
completed correctly, the participant completing the
questionnaire had a history of cancer or there was no
cancer in the family (see Fig. 1 for details). Four hundred
ninety-nine met inclusion criteria and were reviewed. 359
(71.9 %) participants had at least one family member with
breast or colon cancer; 282 (56.5 %) had at least one family
member with breast cancer and 123 (24.6 %) had at least
one family member with colorectal cancer. 66 (13.2 %) of
participants had member(s) of the family with breast and
colorectal cancer.
Identification of candidates for high risk breast cancer
screening or referral for hereditary breast cancer
counseling
Using the Claus Model, we identified 18 individuals (18/
499 = 3.6 %) who had a greater than 20 % lifetime risk of
breast cancer (based on family history) and would there-
fore be candidates for high risk screening according to
ACS guidelines. 5 of these 18 (28 %) individuals were
identified using only first degree family information
(Table 1).
Using the RST, we identified 9 individuals (9/499 = 1.8 %)
who would be candidates for referral for hereditary breast
cancer counseling. 50 % as many women who met criteria
Fig. 1 Consort diagram. Sixty-six family histories have both colorectal cancer and breast and/or ovarian family history and were counted in
both groups
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for high risk breast cancer screening met criteria for high
risk breast cancer genetic referral. Using only first degree
family information, 7 of these 9 (77 %) individuals would be
candidates for genetics referral.
Identification of candidates for high risk colon cancer
screening or referral for hereditary colon cancer
counseling
Using the ACS guidelines for high risk colon cancer
screening, we identified 62 individuals (62/499 = 12 %)
who would be candidates for high risk colon cancer
screening. Using only first degree information, 50 of these
62 (81 %) individuals would be candidates for high risk
screening (Table 1).
Using modified Amsterdam II criteria we identified 31
candidates (31/499 = 6.2 %) for referral for screening for
hereditary colon cancer. 50 % of women who met cri-
teria for colon cancer genetics referral met criteria for
high risk colon cancer screening. Using just a first de-
gree family history, 10 of 31 (32 %) of these individuals
would be candidates for referral.
Discussion
To our knowledge, this is the first study evaluating the
added value of an extended family history (vs limited or
1st degree only) using current professional society cancer
screening guidelines. Using guidelines from the ACS,
72 % of candidates for high risk breast cancer screening
and 19 % of candidates for high risk colon cancer
screening would have been excluded if extended (2nd
degree) family history was not taken into account (Fig. 2).
Additionally, taking only a first degree family history
would have failed to identify 22 and 67 % of candidates for
referral for genetic counseling for hereditary breast or
colon cancer, respectively (using the RST and Amsterdam
II criteria) (Fig. 2).
While the gold standard pedigree is a five generation
pedigree, this can take over one hour to obtain and is
not practical in the primary care setting. Many primary
care providers take only a first degree family history. In
surveys conducted, less than half of primary care pro-
viders and only 65 % of oncologists reported always
obtaining a second degree family history [11, 20].
We have shown that taking such a limited family history
(1st degree relatives only) would fail to identify a signifi-
cant number of individuals who would be candidates for
high risk cancer screening or referral for cancer genetic
counseling. This supports ASCO’s recent recommenda-
tions that a minimum family history for cancer patients
include 1st and 2nd degree family history information [9].
Our study does have limitations that must be considered.
All study participants were female and of predominantly
Fig. 2 Graph depicting the percentage eligible for screening that would be missed if an extended family history was not utilized
Table 1 Numbers of individuals in each group who met criteria for high risk cancer screening and/or referral for genetic counseling
and testing
Total identified # and % of total cohort 1st degree 2nd degree
Screening
Breast cancer 18 (3.6 %) 5 13
Colon cancer 62 (12 %) 50 12
Referral for GC/GT
Breast cancer 9 (1.8 %) 7 2
Colon cancer 31 (6.2 %) 10 21
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Caucasian background. Family histories were obtained from
women reporting for mammography centers creating po-
tential selection bias as women with a positive breast cancer
family history are at increased likelihood to be up-to-date
for mammography screening [20]. Our family history data
was obtained in 2001–2002; however, the technology for
taking a family history has not changed. In fact, we still use
this same questionnaire in clinic today.
Conclusions
We have shown that a significant proportion of candi-
dates for high risk breast and colorectal cancer screening
and genetic referral would be excluded if family history
is limited to first degree family history. Our data set is
small and these conclusions should be validated in a lar-
ger and more diverse data set.
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